跳至主要内容
临床试验/TCTR20210929009
TCTR20210929009尚未招募3 期

Early inhaled fluticasone use for the prevention of bronchopulmonary dysplasia in premature infants: a randomized controlled trial

Faculty of Medicine, Prince of Songkla University0 个研究点目标入组 146 人开始时间: 2021年9月29日最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
发起方
入组人数
146

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
1 Hours 至 24 Hours(—)
性别
All

入选标准

  • 1. Born in hospital and admit in PSU NICU
  • 2. Preterm BW less than 1500 g and GA less than or equal 32 weeks
  • 3. Need for assisted, invasive mechanical ventilation within 24 h of life and need noninvasive ventilation (NIV) if extubation
  • 4. Neonate has not been intervened from another RCT study

排除标准

  • 1. Major congenital anomalies, chromosomal abnormalities, congenital cyanotic heart disease
  • 2. Grade 4 intraventricular hemorrhage occurring before enrollment
  • 3. Severe birth asphyxia or HIE
  • 4. Palliative care
  • 5. Evidence of sepsis (abnormal laboratory data and/or unexplained circulatory failure) before enrollment
  • 6. Hyperglycemia (blood glucose concentration more than 180 mgdL) before enrollment
  • 7. Hypertension more than 95th percentile of systolic blood pressure by GA before enrollment
  • 8. Parents decision not to participate

研究者

发起方
Faculty of Medicine, Prince of Songkla University

相似试验

进行中(未招募)
不适用
A 6-month study to assess the safety and benefit of inhaled fluticasone propionate/salmeterol combination compared with inhaled fluticasone propionate in the treatment of adolescents (12 years and over) and adults with asthma.AsthmaMedDRA version: 17.1Level: PTClassification code 10003553Term: AsthmaSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2011-001644-29-CZGlaxoSmithKline Research & Development Limited11,664
终止
4 期
Reducing periOperative Adverse Respiratory events (ROAR) in children undergoing adenotonsillectomy who present with recurrent respiratory symptomsPost-operative adverse respiratory eventsAnaesthesiology - Other anaesthesiologyRespiratory - Other respiratory disorders / diseases
ACTRN12619000243112Telethon Kids Institute18
招募中
2 期
Efficacy of intranasal fluticasone furoate for prevention chronic rhinosinusitis in nasopharyngeal carcinoma patient: A randomized controlled trialPost radiation chronic rhinosinusitis in nasopharyngeal carcinoma patientsRhinosinusitisRadiation
TCTR20210203001Mahidol university25
已完成
3 期
DOES USE OF INHALED FLUTICASONE PRIOR TO AN ADENOSINE 5'MONOPHOSPHATE (AMP) BRONCHIAL PROVOCATION TEST AFFECT THE PERCEPTION OF DYSPNOEA?AsthmaRespiratory - AsthmaInflammatory and Immune System - AllergiesAllergic Rhinitis
ACTRN12605000611628Woolcock Institute of Medical Research12
进行中(未招募)
不适用
A study of the Effects of Inhaled Fliticasone Furotate/GW642444 versus Placebo on HPA Axis of Adolescent and Adult Asthmatics.Adolescent (12-17 years) and Adult AsthmathicsMedDRA version: 12.1Level: LLTClassification code 10003553Term: Asthma
EUCTR2009-017669-44-PLGlaxoSmithKline185